<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(6)</volume><submitter>Jiang F</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Previous studies have revealed the significant roles of SHC SH2 domain-binding protein 1 (SHCBP1) in occurrence and progression of cancers, but there is no pan-cancer analysis of SHCBP1.&lt;h4>Methods&lt;/h4>In this study, we explored the potential carcinogenic role of SHCBP1 across 33 tumors from the TCGA and GTEx databases. We investigated SHCBP1 expression, prognosis, genetic alterations, tumor mutational burden (TMB) score, microsatellite instability (MSI) and tumor microenvironment from TIMER2, GEPIA2, UALCAN and cBioPortal databases. Moreover, the cellular functions and potential mechanisms were evaluated by GO and KEGG analysis. Besides, the mRNA expression of SHCBP1 was examined using qRT-PCR assay in gastrointestinal cancers.&lt;h4>Results&lt;/h4>SHCBP1 was significantly up</pubmed_abstract><journal>Aging</journal><pagination>2066-2081</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10085602</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets.</pubmed_title><pmcid>PMC10085602</pmcid><pubmed_authors>Ge C</pubmed_authors><pubmed_authors>Cao L</pubmed_authors><pubmed_authors>Fang H</pubmed_authors><pubmed_authors>Jiang F</pubmed_authors><pubmed_authors>Fang D</pubmed_authors><pubmed_authors>Yu H</pubmed_authors><pubmed_authors>Shi Y</pubmed_authors><pubmed_authors>Jian H</pubmed_authors><pubmed_authors>Lan S</pubmed_authors><pubmed_authors>Zhu J</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Lei T</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets.</name><description>&lt;h4>Background&lt;/h4>Previous studies have revealed the significant roles of SHC SH2 domain-binding protein 1 (SHCBP1) in occurrence and progression of cancers, but there is no pan-cancer analysis of SHCBP1.&lt;h4>Methods&lt;/h4>In this study, we explored the potential carcinogenic role of SHCBP1 across 33 tumors from the TCGA and GTEx databases. We investigated SHCBP1 expression, prognosis, genetic alterations, tumor mutational burden (TMB) score, microsatellite instability (MSI) and tumor microenvironment from TIMER2, GEPIA2, UALCAN and cBioPortal databases. Moreover, the cellular functions and potential mechanisms were evaluated by GO and KEGG analysis. Besides, the mRNA expression of SHCBP1 was examined using qRT-PCR assay in gastrointestinal cancers.&lt;h4>Results&lt;/h4>SHCBP1 was significantly up</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Mar</publication><modification>2025-04-04T20:38:54.767Z</modification><creation>2025-04-04T20:38:54.767Z</creation></dates><accession>S-EPMC10085602</accession><cross_references><pubmed>36920183</pubmed><doi>10.18632/aging.204591</doi></cross_references></HashMap>